-
Article | 2025.05.16
European Consortium for Zoonotic and Emerging Viruses - EURL-PH-ERZV
Member of the Consortium of EU Public Health Reference Laboratories for emerging, rodent-borne and zoonotic viral pathogens (EURL-PH-ERZV)
-
News | 2025.05.21
Bacteria use the same tools to resist antibiotics and viruses
The severity of the bacterial antibiotic resistance phenomenon is growing, creating a major public health problem. One possible alternative to antibiotics involves the use of phages, or viruses that infect bacteria. However, a recent study has demonstrated that one of the principal resistance mechanisms used by bacteria against antibiotics is also used against phages. This work highlights the...
-
News | 2023.03.22
The origins of SARS-CoV-2: the search goes on
Where did SARS-CoV-2 come from? How did this virus enter the human population? These questions still remain unanswered. In June 2022, a group of experts, the Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) commissioned by the World Health Organization (WHO), published a report on the origin of coronavirus but was unable to draw a definitive conclusion. Since then, research has...
-
News | 2016.02.14
Birdy: assessing the impact of resistant bacterial infections in young children
The research program BIRDY is focused on bacterial infections, including resistant, in small children. On the occasion of the publication in The Lancet of a correspondence calling for accelerated efforts in research and public health in the fight against neonatal bacterial infection and antibiotic resistance in low-income countries, Dr. Awa Ndir, epidemiologist at the ...
-
News | 2018.03.23
Multiscale structure of the Escherichia coli genome
The Escherichia coli bacterium is a major focus of research in biology. But the higher-order organization of its genome had yet to be investigated using techniques such as chromosome conformation capture (3C/Hi-C). In a paper published in the journal Cell, scientists from the Institut Pasteur revealed using this approach the existence of several levels of chromosomal folding linked to known...
-
Document de presse | 2018.06.01
Announcement of the 2018 ALBERT EINSTEIN World Award of Science
Prof. Jean-Pierre Changeux, Emeritus Professor of Neuroscience at the Institut Pasteur and Collège de France, where he was Chair of Cellular Communications from 1976 to 2006, and at the International Faculty, Kavli Institute for Brain & Mind, University of California (San Diego), has been selected as the winner of the 2018 ALBERT EINSTEIN World Award of Science. The prize is awarded in...
-
News | 2018.07.02
Roman Thibeaux’s joust with bacterial armor
Countering the bacteria responsible for leptospirosis by attacking the "shield" they make to protect themselves: this is the strategy that Roman Thibeaux, a young researcher at the Institut Pasteur de Nouvelle-Calédonie is trying to develop. Born on the island, he left the South Pacific region for a decade before coming back better armed.Roman Thibeaux has been immersed in a medical environment...
-
News | 2018.10.17
Claude Flamand : predicting epidemics with satellite images
Settled in Cayenne for 11 years, Claude Flamand heads the Epidemiology Unit at the Institut Pasteur de la Guyane. Since 2014, this epidemiologist and biostatistician works with the French National Centre for Space Studies to predict dengue epidemics in time and space thanks to satellite imaging."Car, helicopter, canoe, we used every possible means to reach people everywhere in French Guiana",...
-
News | 2019.10.25
Exhibition in honor of Jules Bordet at the Université libre de Bruxelles
On October 8, 2019, the Université libre de Bruxelles inaugurated an exhibition entitled "100th anniversary of a Nobel Prize – Jules Bordet". Developed in collaboration with the Institut Pasteur, this exhibition pays tribute to Institut Pasteur scientist Jules Bordet, who was awarded the 1919 Nobel Prize in Physiology or Medicine for his work on immunity. The exhibition will run until December 21...
-
Document de presse | 2020.05.26
COVID-19: the vast majority of patients with a minor form develop neutralizing antibodies
Teams from Strasbourg University Hospital and the Institut Pasteur carried out a study among hospital staff on the two sites of Strasbourg University Hospital. After observing 160 people with minor forms of COVID-19, the scientists concluded that nearly all the patients developed antibodies within two weeks of being infected. In 98% of the patients, neutralizing antibodies were detected after 28...